课题基金 / 基金详情

TIMP EXPRESSION BY NORMAL LYMPHOCYTES AND IN LYMPHOID NEOPLASMS

TIMP EXPRESSION BY NORMAL LYMPHOCYTES AND IN LYMPHOID NEOPLASMS
正常淋巴细胞和淋巴肿瘤中的 TIMP 表达
批准号:
5201033
负责人:
M STETLER-STEVENSON
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

M STETLER-STEVENSON的其他基金

相似基金

相关文献

中文摘要
翻译
我们研究了TIMP-1在淋巴组织中的表达。TIMP-1 分离的外周血B细胞或扁桃体B细胞不表达 细胞,即使在一组细胞因子的刺激下也是如此。TIMP-1是 在低度恶性B细胞淋巴瘤细胞系中也不表达。TIMP-1 然而,每八个Burkitt细胞系中就有四个表达 学习。体外研究表明,表达基因的细胞系 TIMP-1具有较高的侵袭潜能。在裸鼠体内,TIMP-1 表达细胞系具有更强的致瘤性和侵袭性。TIMP-1 阴性细胞系无侵袭性,肿瘤发生率低 队形。表达TIMP-1的细胞株具有抗寒性 休克诱导细胞凋亡而TIMP-1阴性的细胞系 经历细胞凋亡。我们已经用TIMP-1阴性细胞株感染了 含TIMP-1的逆转录病毒载体及其分离的TIMP-1 表达克隆。TIMP-1的表达似乎增加了 与单纯逆转录病毒相比,生长速度更快。我们目前正在研究 TIMP-1在侵袭性和细胞凋亡中的作用
英文摘要
We have studied the expression of TIMP-1 in lymphoid tissue. TIMP-1 is not expressed by isolated peripheral blood B-cells or tonsillar B- cells, even after stimulation with a panel of cytokines. TIMP-1 is also not expressed by low grade B-cell lymphoma cell lines. TIMP-1 is, however, expressed by four out of eight Burkitt cell lines studied. In vitro studies indicate that the cell lines expressing TIMP-1 have a higher invasion potential. In the nude mouse, TIMP-1 expressing cell lines are more tumorigenic and invasive. The TIMP-1 negative cell lines are not invasive and have a low incidence of tumor formation. The TIMP-1 expressing cell lines are resistant to cold shock induced apoptosis while the TIMP-1 negative cell lines readily undergo apoptosis. We have infected TIMP-1 negative cell lines with a retroviral construct containing TIMP-1 and have isolated TIMP-1 expressing clones. TIMP-1 expression appears to have increased the growth rate compared to retrovirus alone. We are currently studying the effect of TIMP-1 on invasiveness and apoptosis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
EXPRESSION OF ONCOGENES IN LYMPHOPROLIFERATIVE DISORDERS
EXPRESSION OF ONCOGENES IN LYMPHOPROLIFERATIVE DISORDERS
ANEUPLOIDY AND CELL CYCLE FRACTIONS IN BENIGN AND MALIGNANT TUMORS
ANEUPLOIDY AND CELL CYCLE FRACTIONS IN BENIGN AND MALIGNANT TUMORS
海外基金